Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03001570
Title Accelerated Modulated Fractionation (SIB-IMRT) for Head and Neck District (FAMOSO)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors European Institute of Oncology

oropharynx cancer

laryngeal squamous cell carcinoma

hypopharynx cancer


Cetuximab + Radiotherapy

Age Groups: adult | senior
Covered Countries ITA

No variant requirements are available.